据中国医药工业公司上半年召开的全国化学药品计划座谈会上分析,今年全国一些主要品种供应紧缺的原因如下: 一,因原料不足影响供应的品种有: 乙底酚针、片、氯脂醒片、胆影钠针、异戍巴比妥钠针、酚妥拉明针、新霉素片、泰尔登片、安宫黄体酮片、氟灭酸片、眼压平片、以及原料药溴化钠、溴化钾、溴化铵等。二,因国家分配稀有金属不足,影响医药生产的品种有: 次水杨酸铋针、以及原料药硝酸 According to the symposium held by China Pharmaceutical Industry Corporation on the national chemical program in the first half of this year, the reasons for the shortage of supply of some major varieties of the country this year are as follows: 1. The varieties affected by the shortage of raw materials are as follows: Pancreatic sodium needle, sodium pantothenate needle, phentolamine needle, neomycin tablets, tertron tablets, Annong progesterone tablets, flu mefenamic acid tablets, intraocular pressure tablets, and APIs Sodium bromide, potassium bromide, ammonium bromide and the like. Second, due to lack of distribution of rare metals, the impact of pharmaceutical production varieties are: sub-salicylic acid bismuth, and raw materials, nitric acid